While the appetite for home health and home care dealmaking remains strong, other health care subsectors are catching up, reports Home Health Care News.
Coming off a record-breaking 2021 for M&A deals, the home-based sector saw a slightly down Q1 in 2022. However, experts say that M&A players are taking their time with deals, and even though the number of deals is lower, the valuations in those deals have not dipped.
Home health and hospice M&A transactions sat comfortably in second among other health care subsectors for Q1 2022. Read more.
